Eugene Boland, Ph.D., has over 25 years in laboratory research, with a specific focus on developing engineering solutions for cardiovascular diseases as well as chronic wounds. His materials expertise extends from bioinert metals and ceramics to bioactive and bioresorbable electrospun polymers and proteins. After receiving his Bachelor of Science in Biomedical Engineering from Marquette University in 1994, Dr. Boland went on to receive his Ph.D. in Biomedical Engineering from Virginia Commonwealth University in 2004 after 6 years in cardiovascular medical device field.
Dr. Boland has held senior engineering positions with companies such as St. Jude Medical Inc., Cordis (a Johnson & Johnson Co.) and Cryolife before completing his doctorate. More recently he has held the position of principal scientist with Tissue Genesis, Inc., and Chief of Regenerative Medicine at the University of Louisville’s Cardiovascular Innovation Institute before joining Techshot in the role of Chief Scientist in 2013.
He is currently leading a collaborative team managing the Techshot BioFabrication Facility (BFF) installed aboard the International Space Station both for our own tissue and neo-organ commercial efforts and as a materials research and development platform for the microgravity community. In addition, he is leading efforts at Techshot to develop biologically-derived inks (mimetic bioinks) to take advantage of the unique capability that microgravity offers in tissue development as well as a method to induce, expand and differentiate human induced pluripotent stem cells in a microgravity environment. He has led numerous past projects including a feasibility study on Martian Ecopoiesis using bacteria and algae for nitrogen fixation and oxygen production.